Altre lingue MAIA Biotechnology, Inc.

Azioni

MAIA

US5526411021

Mercato chiuso - Nyse Altri mercati azionari 22:00:00 07/06/2024			Variaz. 5gg	Var. 1 gen.
3,86 ^USD	+16,27%		-18,74%	+229,91%

04/06	Maia Biotechnology rivela nuovi dati clinici che dimostrano la forte efficacia di Thio nel carcinoma polmonare non a piccole cellule	CI
14/05	MAIA Biotechnology, Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

MAIA Biotechnology Shares Rise After FDA's Telomerase Inhibitor Approval Shows Viability of Such Therapies	07/06
MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy	07/06
MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent	06/06
Groundbreaking Study by MAIA Biotechnology (NYSE: MAIA) Indicates Promising New Treatment for Advanced Lung Cancer	06/06
MAIA BIOTECHNOLOGY REVEALS NEW CLINICAL DATA SHOWING THIO'S STRONG EFFICACY IN NON-SMALL CELL LUNG CANCER	05/06
MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer	04/06
Maia Biotechnology Reveals New Clinical Data Showing Thio?s Strong Efficacy in Non-Small Cell Lung Cancer	04/06
MAIA Biotechnology : Poster (June 2024)	03/06
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation	21/05
MAIA Biotechnology, Inc. announced a financing transaction	21/05
MAIA BIOTECHNOLOGY TO PRESENT AT THE BIO INTERNATIONAL CONVENTION 2024	20/05
MAIA BIOTECHNOLOGY ABSTRACT ACCEPTED FOR POSTER PRESENTATION AT AMERICAN SOCIETY OF CLINICAL ONCOLOGY 2024 ANNUAL MEETING	17/05
MAIA Biotechnology to Present at the BIO International Convention 2024	17/05
MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting	16/05
MAIA Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement	30/04
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement	29/04
Maia Biotechnology Insider Bought Shares Worth $299,409, According to a Recent SEC Filing	26/04
MAIA Biotechnology Announces $1.00 Million Private Placement	23/04
MAIA Biotechnology, Inc. announced that it expects to receive $0.664994 million in funding	22/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue MAIA Biotechnology, Inc.

Azioni

MAIA

US5526411021

Altre lingue

Filtri